{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:54:56Z","timestamp":1794246896714,"version":"4.9.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017653","name":"Fonds Sp\u00e9ciaux de Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fonds de Recherche Clinique"},{"DOI":"10.13039\/501100022434","name":"Walloon excellence in life sciences and biotechnology","doi-asserted-by":"publisher","award":["WELBIO-CR-2022A-02"],"award-info":[{"award-number":["WELBIO-CR-2022A-02"]}],"id":[{"id":"10.13039\/501100022434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["FNRS-CDR J.0085.21"],"award-info":[{"award-number":["FNRS-CDR J.0085.21"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["program no. 40007505"],"award-info":[{"award-number":["program no. 40007505"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06500-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:19:00Z","timestamp":1751397540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study"],"prefix":"10.1038","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04805944","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Julien","family":"De Greef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khoi Nguyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Puel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Cyr","family":"Yombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Vandercam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Elens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u00efla","family":"Belkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice D.","family":"Cani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"11","key":"6500_CR1","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/hiv.13542","volume":"24","author":"J Ambrosioni","year":"2023","unstructured":"Ambrosioni, J. et al. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Med. 24(11), 1126\u20131136 (2023).","journal-title":"HIV Med."},{"key":"6500_CR2","unstructured":"WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach 2021. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240031593"},{"issue":"1","key":"6500_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2055-6640(20)30277-6","volume":"5","author":"A Hill","year":"2019","unstructured":"Hill, A., Waters, L. & Pozniak, A. Are new antiretroviral treatments increasing the risks of clinical obesity?. J. Virus Erad. 5(1), 41\u201343 (2019).","journal-title":"J. Virus Erad."},{"key":"6500_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101412","volume":"48","author":"S Kanters","year":"2022","unstructured":"Kanters, S. et al. Evidence synthesis evaluating body weight gain among people treating HIV with antiretroviral therapy\u2014A systematic literature review and network meta-analysis. EClinicalMedicine 48, 101412 (2022).","journal-title":"EClinicalMedicine"},{"issue":"6","key":"6500_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cid\/ciz999","volume":"71","author":"PE Sax","year":"2020","unstructured":"Sax, P. E. et al. Weight gain following initiation of antiretroviral therapy: Risk factors in randomized comparative clinical trials. Clin. Infect. Dis. 71(6), 1379\u20131389 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"6500_CR6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciae474","volume":"80","author":"CD Lahiri","year":"2024","unstructured":"Lahiri, C. D. et al. Short and long-term body weight change following the switch to or the addition of integrase inhibitors in persons with HIV differs by sex. Clin. Infect. Dis. 80, 575\u2013584 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"6500_CR7","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1126\/science.aag2770","volume":"356","author":"N Koppel","year":"2017","unstructured":"Koppel, N., Maini Rekdal, V. & Balskus, E. P. Chemical transformation of xenobiotics by the human gut microbiota. Science 356, 6344 (2017).","journal-title":"Science"},{"issue":"7698","key":"6500_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555(7698), 623\u2013628 (2018).","journal-title":"Nature"},{"key":"6500_CR9","unstructured":"Villanueva-Mill\u00e1n, M. J., P\u00e9rez-Matute, P., Recio-Fern\u00e1ndez, E., Lezana Rosales, J. M., Oteo, J. A. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. 1758\u20132652 (Electronic)."},{"issue":"1","key":"6500_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/COH.0000000000000428","volume":"13","author":"S Pinto-Cardoso","year":"2018","unstructured":"Pinto-Cardoso, S., Klatt, N. R. & Reyes-Ter\u00e1n, G. Impact of antiretroviral drugs on the microbiome: Unknown answers to important questions. Curr. Opin. HIV AIDS 13(1), 53\u201360 (2018).","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"1","key":"6500_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","volume":"1","author":"PD Cani","year":"2019","unstructured":"Cani, P. D. et al. Microbial regulation of organismal energy homeostasis. Nat. Metab. 1(1), 34\u201346 (2019).","journal-title":"Nat. Metab."},{"issue":"5","key":"6500_CR12","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/oby.22175","volume":"26","author":"M Rastelli","year":"2018","unstructured":"Rastelli, M., Knauf, C. & Cani, P. D. Gut microbes and health: A focus on the mechanisms linking microbes, obesity, and related disorders. Obesity (Silver Spring) 26(5), 792\u2013800 (2018).","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"6500_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41574-022-00794-0","volume":"19","author":"M Van Hul","year":"2023","unstructured":"Van Hul, M. & Cani, P. D. The gut microbiota in obesity and weight management: microbes as friends or foe?. Nat. Rev. Endocrinol. 19(5), 258\u2013271 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"6500_CR14","first-page":"98","volume":"20","author":"J De Greef","year":"2025","unstructured":"De Greef, J. et al. Dolutegravir and risk of neuropsychiatric adverse events: A pharmacogenetic study. J. Infect. Dis. 20, 98 (2025).","journal-title":"J. Infect. Dis."},{"issue":"8","key":"6500_CR15","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37(8), 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"6500_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich, N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6(1), 90 (2018).","journal-title":"Microbiome"},{"issue":"11","key":"6500_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009581","volume":"17","author":"MS Robeson II","year":"2021","unstructured":"Robeson, M. S. II. et al. RESCRIPt: Reproducible sequence taxonomy reference database management. PLoS Comput. Biol. 17(11), e1009581 (2021).","journal-title":"PLoS Comput. Biol."},{"issue":"4","key":"6500_CR18","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8(4), e61217 (2013).","journal-title":"PLoS ONE"},{"key":"6500_CR19","unstructured":"Lahti, L. & Shetty, S. Tools for microbiome analysis in R. Bioconductor (2017)."},{"key":"6500_CR20","unstructured":"Wickham, H., Chang, W., Henry, L., Pedersen, T. L., Takahashi, K., Wilke, C., et al. ggplot2: Create Elegant Data Visualisations Using the Grammar of Graphics. CRAN (2023)."},{"key":"6500_CR21","unstructured":"Kassambara, A. ggpubr: \u2018ggplot2\u2019 Based Publication Ready Plots. 0.6.0 ed: CRAN (2023)."},{"key":"6500_CR22","unstructured":"Hunter, J. D. & Droettboom, M. matplotlib. pypi.org (2023)."},{"issue":"3","key":"6500_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2020-323778","volume":"71","author":"T Le Roy","year":"2022","unstructured":"Le Roy, T. et al. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut 71(3), 534\u2013543 (2022).","journal-title":"Gut"},{"issue":"2","key":"6500_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00125-023-06032-0","volume":"67","author":"E Moens de Hase","year":"2024","unstructured":"Moens de Hase, E. et al. Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention. Diabetologia 67(2), 333\u2013345 (2024).","journal-title":"Diabetologia"},{"issue":"1","key":"6500_CR25","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12879-022-07091-1","volume":"22","author":"R Bai","year":"2022","unstructured":"Bai, R., Lv, S., Wu, H. & Dai, L. Effects of different integrase strand transfer inhibitors on body weight in patients with HIV\/AIDS: A network meta-analysis. BMC Infect. Dis. 22(1), 118 (2022).","journal-title":"BMC Infect. Dis."},{"issue":"12","key":"6500_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/ofid\/ofab542","volume":"8","author":"BR Wood","year":"2021","unstructured":"Wood, B. R. & Huhn, G. D. Excess weight gain with integrase inhibitors and Tenofovir alafenamide: What is the mechanism and does it matter?. Open Forum Infect. Dis. 8(12), 542 (2021).","journal-title":"Open Forum Infect. Dis."},{"issue":"4","key":"6500_CR27","doi-asserted-by":"publisher","first-page":"e25702","DOI":"10.1002\/jia2.25702","volume":"24","author":"PW Mallon","year":"2021","unstructured":"Mallon, P. W. et al. Weight gain before and after switch from TDF to TAF in a U.S. cohort study. J. Int. AIDS Soc. 24(4), e25702 (2021).","journal-title":"J. Int. AIDS Soc."},{"issue":"3","key":"6500_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jac\/dkad007","volume":"78","author":"S Grabar","year":"2023","unstructured":"Grabar, S. et al. Striking differences in weight gain after cART initiation depending on early or advanced presentation: Results from the ANRS CO4 FHDH cohort. J. Antimicrob. Chemother. 78(3), 757\u2013768 (2023).","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"6500_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/ofid\/ofac291","volume":"9","author":"ML Verburgh","year":"2022","unstructured":"Verburgh, M. L. et al. One in 10 virally suppressed persons with HIV in The Netherlands experiences \u226510% weight gain after switching to Tenofovir alafenamide and\/or integrase strand transfer inhibitor. Open Forum Infect. Dis. 9(7), 291 (2022).","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"6500_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/hiv.12128","volume":"15","author":"JE Lake","year":"2014","unstructured":"Lake, J. E. et al. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: The women, integrase and fat accumulation trial. HIV Med. 15(7), 431\u2013441 (2014).","journal-title":"HIV Med."},{"key":"6500_CR31","first-page":"55","volume":"21","author":"E Martinez","year":"2018","unstructured":"Martinez, E. et al. 48-Week changes in biomarkers in subjects with high cardiovascular risk switching from ritonavir-boosted protease inhibitors to dolutegravir: the NEAT022 study. J. Int. AIDS Soc. 21, 55 (2018).","journal-title":"J. Int. AIDS Soc."},{"issue":"3","key":"6500_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/infdis\/jiv004","volume":"212","author":"CO Hileman","year":"2015","unstructured":"Hileman, C. O. et al. Differential reduction in monocyte activation and vascular inflammation with integrase inhibitor-based initial antiretroviral therapy among HIV-infected individuals. J. Infect. Dis. 212(3), 345\u2013354 (2015).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"6500_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","volume":"6","author":"JR Koethe","year":"2020","unstructured":"Koethe, J. R. et al. HIV and antiretroviral therapy-related fat alterations. Nat. Rev. Dis. Primers 6(1), 48 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"6500_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/cells11111841","volume":"11","author":"K Ngono Ayissi","year":"2022","unstructured":"Ngono Ayissi, K. et al. Inhibition of adipose tissue beiging by HIV integrase inhibitors, dolutegravir and bictegravir, is associated with adipocyte hypertrophy, hypoxia, elevated fibrosis, and insulin resistance in simian adipose tissue and human adipocytes. Cells 11(11), 32 (2022).","journal-title":"Cells"},{"key":"6500_CR35","doi-asserted-by":"publisher","first-page":"1133556","DOI":"10.3389\/frph.2023.1133556","volume":"5","author":"T Tovar Sanchez","year":"2023","unstructured":"Tovar Sanchez, T. et al. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. Front. Reprod. Health 5, 1133556 (2023).","journal-title":"Front. Reprod. Health"},{"issue":"12","key":"6500_CR36","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1093\/cid\/ciac355","volume":"75","author":"JA O'Halloran","year":"2022","unstructured":"O\u2019Halloran, J. A. et al. Integrase strand transfer inhibitors are associated with incident diabetes mellitus in people with human immunodeficiency virus. Clin. Infect. Dis. 75(12), 2060\u20132065 (2022).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"6500_CR37","doi-asserted-by":"publisher","first-page":"21526","DOI":"10.7448\/IAS.20.1.21526","volume":"20","author":"MJ Villanueva-Mill\u00e1n","year":"2017","unstructured":"Villanueva-Mill\u00e1n, M. J., P\u00e9rez-Matute, P., Recio-Fern\u00e1ndez, E., Lezana Rosales, J. M. & Oteo, J. A. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients. J. Int. AIDS Soc. 20(1), 21526 (2017).","journal-title":"J. Int. AIDS Soc."},{"issue":"4","key":"6500_CR38","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s40121-022-00654-4","volume":"11","author":"P Villoslada-Blanco","year":"2022","unstructured":"Villoslada-Blanco, P. et al. Integrase inhibitors partially restore bacterial translocation, inflammation and gut permeability induced by HIV infection: Impact on gut microbiota. Infect. Dis. Ther. 11(4), 1541\u20131557 (2022).","journal-title":"Infect. Dis. Ther."},{"issue":"3","key":"6500_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41575-023-00867-z","volume":"21","author":"PD Cani","year":"2024","unstructured":"Cani, P. D. & Van Hul, M. Gut microbiota in overweight and obesity: Crosstalk with adipose tissue. Nat. Rev. Gastroenterol. Hepatol. 21(3), 164\u2013183 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"6500_CR40","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/ajcn\/nqab150","volume":"114","author":"J Muralidharan","year":"2021","unstructured":"Muralidharan, J. et al. Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus Study. Am. J. Clin. Nutr. 114(3), 1148\u20131158 (2021).","journal-title":"Am. J. Clin. Nutr."},{"key":"6500_CR41","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8317","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing. PeerJ 8, e8317 (2020).","journal-title":"PeerJ"},{"key":"6500_CR42","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/advances\/nmy078","volume":"10","author":"A Cuevas-Sierra","year":"2019","unstructured":"Cuevas-Sierra, A., Ramos-Lopez, O., Riezu-Boj, J. I., Milagro, F. I. & Martinez, J. A. Diet, gut microbiota, and obesity: Links with host genetics and epigenetics and potential applications. Adv. Nutr. 10, S17\u2013S30 (2019).","journal-title":"Adv. Nutr."},{"key":"6500_CR43","unstructured":"Ishizaka, A., Koga, M., Mizutani, T., Parbie, P. K., Prawisuda, D., Yusa, N., et al. Unique gut microbiome in HIV patients on antiretroviral therapy (ART) suggests association with chronic inflammation. 2165\u20130497 (Electronic)."},{"key":"6500_CR44","unstructured":"Lozupone, C. A., Li, M., Fau-Campbell, T. B., Campbell, T., Fau-Flores, S. C., Flores, S. C., Fau-Linderman, D., Linderman, D., Fau-Gebert, M. J., Gebert, M., Fau-Knight, R., et al. Alterations in the gut microbiota associated with HIV-1 infection. 1934\u20136069 (Electronic)."},{"issue":"5","key":"6500_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/19490976.2018.1560768","volume":"10","author":"A Machiavelli","year":"2019","unstructured":"Machiavelli, A., Duarte, R. T. D., Pires, M. M. D. S., Z\u00e1rate-Blad\u00e9s, C. R. & Pinto, A. R. The impact of in utero HIV exposure on gut microbiota, inflammation, and microbial translocation. Gut Microbes 10(5), 599\u2013614 (2019).","journal-title":"Gut Microbes"},{"key":"6500_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114388","volume":"160","author":"N Mena-V\u00e1zquez","year":"2023","unstructured":"Mena-V\u00e1zquez, N. et al. Adiposity is associated with expansion of the genus Dialister in rheumatoid arthritis patients. Biomed. Pharmacother. 160, 114388 (2023).","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"6500_CR47","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-018-0160-1","volume":"24","author":"M Deschasaux","year":"2018","unstructured":"Deschasaux, M. et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24(10), 1526\u20131531 (2018).","journal-title":"Nat. Med."},{"issue":"7695","key":"6500_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555(7695), 210\u2013215 (2018).","journal-title":"Nature"},{"issue":"3","key":"6500_CR49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10620-020-06110-y","volume":"65","author":"S Tuddenham","year":"2020","unstructured":"Tuddenham, S., Koay, W. L. & Sears, C. HIV, sexual orientation, and gut microbiome interactions. Dig. Dis. Sci. 65(3), 800\u2013817 (2020).","journal-title":"Dig. Dis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06500-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06500-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:04:51Z","timestamp":1751400291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06500-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6500"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06500-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval by the local Ethical committee (\n                      Comit\u00e9 d\u2019\u00e9thique Hospitalo-facultaire\n                      from Cliniques universitaires Saint-Luc-UCLouvain; 2020\/30NOV\/593) and regulatory authorities (Eudra-CT Number 2020-001103-17). All participants gave written informed consent before taking part in the study. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The trial is registered with ClinicalTrials.gov, NCT04805944 (registration date 2021\u201303-16).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}},{"value":"PDC is inventor on patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. PDC was co-founder of The Akkermansia Company SA and Enterosys. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22603"}}